Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 1.00 |
| ▸ | P2RY2 | P41231 | 8/20 | 0.82 |
| ▸ | GNG2 | P59768 | 5/20 | 0.77 |
| ▸ | GNB1 | P62873 | 5/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | P2RY4 | P51582 | 8/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | P2RY12 | Q9H244 | 5/20 | 0.60 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.60 |
| ▸ | ENTPD1 | P49961 | 2/20 | 0.60 |
| ▸ | MET | P08581 | 2/20 | 0.60 |
| ▸ | HGF | P14210 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29666889 | 1.00 | PHLPP2 (1.00) | PHLPP2P2RY2GNG2GNB1CYP1A2 | |
| SCHEMBL2854079 | 0.99 | PHLPP2 (0.98) | PHLPP2P2RY2GNG2GNB1CYP1A2 | |
| SCHEMBL8402397 | 0.91 | PHLPP2 (0.84) | PHLPP2P2RY2GNG2GNB1CYP1A2 | |
| SCHEMBL13021512 | 0.91 | GNG2 (0.92) | PHLPP2P2RY2GNG2GNB1CYP1A2 | |
| SCHEMBL11311937 | 0.91 | PHLPP2 (0.82) | PHLPP2P2RY2GNG2GNB1CYP1A2 | |
| SCHEMBL11311121 | 0.90 | PHLPP2 (0.82) | PHLPP2P2RY2GNG2GNB1CYP1A2 | |
| SCHEMBL29356677 | 0.89 | P2RY2 (1.00) | PHLPP2P2RY2P2RY4P2RY12P2RY6 | |
| SCHEMBL13875739 | 0.88 | PHLPP2 (0.79) | PHLPP2P2RY2GNG2GNB1CYP1A2 | |
| SCHEMBL2779595 | 0.87 | GNG2 (1.00) | PHLPP2P2RY2GNG2GNB1CYP1A2 | |
| SCHEMBL9137161 | 0.87 | GNG2 (0.82) | PHLPP2P2RY2GNG2GNB1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108147310-A | A kind of carbon tetrachloride processing centrifuge movement maintenance unit | 徐州工程学院 | 2018-06-12 | — | — | CN | claimed |
| JP-58125755-A | — | — | None | — | — | JP | disclosed |
| JP-58125758-A | — | — | None | — | — | JP | disclosed |
| JP-55133461-A | — | — | None | — | — | JP | disclosed |
| US-20200360392-A1 | DIGALLIC ACID FOR REDUCTION OF INFLAMMATORY CYTOKINE ACTIVITY | ENZO BIOCHEM, INC (US) | 2020-11-19 | — | — | US | disclosed |
| US-20190350936-A1 | METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAIN | ENZO BIOCHEM, INC. (US) | 2019-11-21 | — | — | US | disclosed |
| CN-108147310-A | A kind of carbon tetrachloride processing centrifuge movement maintenance unit | 徐州工程学院 | 2018-06-12 | — | — | CN | disclosed |
| US-20170020883-A1 | METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAIN | ENZO BIOCHEM, INC. (US) | 2017-01-26 | — | — | US | disclosed |
| US-20170020883-A1 | METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAIN | ENZO BIOCHEM, INC. (US) | 2017-01-26 | — | — | US | disclosed |
| CN-106315805-A | Modified straw polypropylene composite flocculant and key production technology thereof | 徐州工程学院 | 2017-01-11 | — | — | CN | disclosed |
| US-20110049444-A1 | COLORED RESIN COMPOSITIONS FOR COLOR FILTER, COLOR FILTER, ORGANIC EL DISPLAY, AND LIQUID-CRYSTAL DISPLAY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-03-03 | — | — | US | disclosed |
| US-20090100611-A1 | Acid Dye Composition of Anthraquinone Dyes | CLARIANT FINANCE (BVI) LIMITED (VG) | 2009-04-23 | — | — | US | disclosed |
| WO-2007028665-A1 | ACID DYE COMPOSITION OF ANTHRAQUINONE DYES | CLARIANT INTERNATIONAL LTD (CH) | 2007-03-15 | — | — | WO | disclosed |
| US-5385842-A | Anthraquinones as inhibitors of sulfide production from sulfate-reducing bacteria | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-31 | — | — | US | disclosed |
| EP-0525073-B1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | DU PONT (US) | 1994-05-25 | — | — | EP | disclosed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | disclosed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | disclosed |
| JP-S58125755-A | ANTHRAQUINONE-TYPE ANIONIC DYE COMPOSITION | SUMITOMO CHEM CO LTD | 1983-07-26 | — | — | JP | disclosed |
| JP-S58125758-A | ANIONIC DYE COMPOSITION | SUMITOMO CHEM CO LTD | 1983-07-26 | — | — | JP | disclosed |
| JP-S55133461-A | ANIONIC DYE FORMULATION | SUMITOMO CHEM CO LTD | 1980-10-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200360392-A1 | DIGALLIC ACID FOR REDUCTION OF INFLAMMATORY CYTOKINE ACTIVITY | LRP6, IL6, IL6ST | PHLPP2 1769/4885P2RY2 1349/4885GNG2 1011/4885 |
| US-20190350936-A1 | METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAIN | LDLR, LRP6, LPAR6 | PHLPP2 505/4885P2RY2 1674/4885GNG2 930/4885 |
| US-20170020883-A1 | METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAIN | LDLR, LRP6, LPAR6 | PHLPP2 505/4885P2RY2 1674/4885GNG2 930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.